Risk of necrotising enterocolitis stage ≥ 2 · feed interruption while monitoring gastric residual
Summary of findings table ‐ Quality and volume of gastric residual showed no clear difference in risk of necrotising enterocolitis stage ≥ 2 compared with quality of gastric residual alone (low certainty).
1 finding from 1 review
Time to achieve full enteral feeding (days) · feed interruption while monitoring gastric residual
1 finding from 1 review
Adherence to antipsychotic medication: number of missed doses, average endpoint data, short term (up to 6 months) · People receiving lipid‐lowering medications
Summary of findings table for the comparison of 'intensified patient… probably leads to higher medication adherence at ≤ 6 months compared with 'usual care' (moderate certainty).
1 finding from 1 review
Medication adherence (dichotomous) · People receiving lipid‐lowering medications
Summary of findings table for the comparison of 'intensified patient… leads to higher medication adherence at > 6 months compared with 'usual care' (high certainty).
1 finding from 1 review
LDL‐C reduction (LDL‐C) · People receiving lipid‐lowering medications
1 finding from 1 review
Reduction in total serum cholesterol at ≤ 6 months (mg/dL) · People receiving lipid‐lowering medications
1 finding from 1 review
Reduction in total serum cholesterol at > 6 mos (mg/dL) · People receiving lipid‐lowering medications
1 finding from 1 review
Perinatal death or severe morbidity · women with non‐reassuring FHR tracing during labour or induction of labour
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Fetal or neonatal mortality · women with non‐reassuring FHR tracing during labour or induction of labour
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Caesarean section · women with non‐reassuring FHR tracing during labour or induction of labour
Summary of findings for IV terbutaline showed no clear difference in caesarean delivery compared with IV nitroglycerin (low certainty).
1 finding from 1 review
Apgar score less than 7 at 5 minutes · women with non‐reassuring FHR tracing during labour or induction of labour
1 finding from 1 review
Umbilical artery pH < 7.0 · women with non‐reassuring FHR tracing during labour or induction of labour
It is very uncertain whether summary of findings for IV terbutaline changes umbilical artery pH < 7.0 compared with IV nitroglycerin (very low certainty).
1 finding from 1 review
Successful intrauterine fetal resuscitation · women with non‐reassuring FHR tracing during labour or induction of labour
Summary of findings for IV terbutaline showed no clear difference in successful intrauterine fetal resuscitation compared with IV nitroglycerin (low certainty).
1 finding from 1 review
Perinatal death or severe morbidity · women for whom a decision had been made to deliver by caesarean section for suspected fetal distress based on FHR monitoring
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Fetal or neonatal mortality · women for whom a decision had been made to deliver by caesarean section for suspected fetal distress based on FHR monitoring
Summary of findings for IV hexoprenaline showed no clear difference in fetal or neonatal mortality compared with no tocolytic agent, whilst awaiting emergency delivery (low certainty).
1 finding from 1 review
Caesarean section · women for whom a decision had been made to deliver by caesarean section for suspected fetal distress based on FHR monitoring
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Apgar score less than 7 at 5 minutes · women for whom a decision had been made to deliver by caesarean section for suspected fetal distress based on FHR monitoring
Summary of findings for IV hexoprenaline showed no clear difference in 5‐minute Apgar score < 7 compared with no tocolytic agent, whilst awaiting emergency delivery (low certainty).
1 finding from 1 review
Low umbilical artery pH (< 7.2 or as defined by trial authors) · women for whom a decision had been made to deliver by caesarean section for suspected fetal distress based on FHR monitoring
Summary of findings for IV hexoprenaline showed no clear difference in umbilical artery pH < 7.2 compared with no tocolytic agent, whilst awaiting emergency delivery (low certainty).
1 finding from 1 review
Abnormal FHR as defined by trial authors (FHR tracing not improved) · women for whom a decision had been made to deliver by caesarean section for suspected fetal distress based on FHR monitoring
Summary of findings for IV hexoprenaline probably leads to lower FHR tracing not improved compared with no tocolytic agent, whilst awaiting emergency delivery (moderate certainty).
1 finding from 1 review
All‐cause mortality · people at increased risk for developing type 2 diabetes
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found